John Mamo

John was awarded the NHMRC Marshall and Warren Award for most innovative and potentially transformative research and in 2021, the title of ‘John Curtin Distinguished Professor’ for translational clinical research discoveries. John leads a team of physiologists and vascular biologists interrogating cerebral capillary dysfunction in a range of neurodegenerative diseases including Alzheimer's, MS and in pain disorders. John has also made major contributions deciphering the role of dietary derived lipoproteins in atherosclerosis and cardiovascular disease, with high-citation publications realised. John hosts substantial multidisciplinary preclinical translational research and clinical trials, including presently as Principal Investigator of an NHMRC-MRFF drug study in Alzheimer’s disease (ACTRN1261000726853) amongst others. John has published ~200 peer reviewed publications and been cited more than 6300 occasions.